|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-11-13
|
|
pubmed:abstractText |
Increased antibacterial use is associated with a greater likelihood of reduced effectiveness as a result of resistance development in the future. The objective of this study was to evaluate the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections (DFIs) from the UK NHS perspective, accounting for the development of antibacterial resistance over time.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
T
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1179-2027
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1045-56
|
|
pubmed:meshHeading |
pubmed-meshheading:19908928-Anti-Bacterial Agents,
pubmed-meshheading:19908928-Bacterial Infections,
pubmed-meshheading:19908928-Cost-Benefit Analysis,
pubmed-meshheading:19908928-Decision Trees,
pubmed-meshheading:19908928-Diabetic Foot,
pubmed-meshheading:19908928-Direct Service Costs,
pubmed-meshheading:19908928-Drug Costs,
pubmed-meshheading:19908928-Drug Resistance, Bacterial,
pubmed-meshheading:19908928-Great Britain,
pubmed-meshheading:19908928-Humans,
pubmed-meshheading:19908928-Models, Biological,
pubmed-meshheading:19908928-Models, Econometric,
pubmed-meshheading:19908928-Penicillanic Acid,
pubmed-meshheading:19908928-Piperacillin,
pubmed-meshheading:19908928-Quality-Adjusted Life Years,
pubmed-meshheading:19908928-Treatment Outcome,
pubmed-meshheading:19908928-beta-Lactams
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK.
|
|
pubmed:affiliation |
Mapi Values, Boston, Massachusetts 02114, USA. Jeroen.jansen@mapivalues.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
